Literature DB >> 31757747

Comparative Analysis of Radiotherapy Linear Accelerator Downtime and Failure Modes in the UK, Nigeria and Botswana.

L M Wroe1, T A Ige2, O C Asogwa2, S C Aruah2, S Grover3, R Makufa4, M Fitz-Gibbon5, S L Sheehy6.   

Abstract

The lack of radiotherapy linear accelerators (linacs) in low- and middle-income countries (LMICs) has been recognised as a major barrier to providing quality cancer care in these regions, together with a shortfall in the number of highly qualified personnel. It is expected that additional challenges will be faced in operating precise, high-technology radiotherapy equipment in these environments, and anecdotal evidence suggests that linacs have greater downtime and higher failure rates of components than their counterparts in high-income countries. To guide future developments, such as the design of a linac tailored for use in LMIC environments, it is important to take a data-driven approach to any re-engineering of the technology. However, no detailed statistical data on linac downtime and failure modes have been previously collected or presented in the literature. This work presents the first known comparative analysis of failure modes and downtime of current generation linacs in radiotherapy centres, with the aim of determining any correlations between linac environment and performance. Logbooks kept by radiotherapy personnel on the operation of their linac were obtained and analysed from centres in Oxford (UK), Abuja, Benin, Enugu, Lagos, Sokoto (Nigeria) and Gaborone (Botswana). By deconstructing the linac into 12 different subsystems, it was found that the vacuum subsystem only failed in the LMIC centres and the failure rate in an LMIC environment was more than twice as large in six of the 12 subsystems compared with the high-income country. Additionally, it was shown that despite accounting for only 3.4% of the total number of faults, linac faults that took more than 1 h to repair accounted for 74.6% of the total downtime. The results of this study inform future attempts to mitigate the problems affecting linacs in LMIC environments.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Accelerator; availability; downtime; failure modes; linac; radiotherapy

Mesh:

Year:  2019        PMID: 31757747     DOI: 10.1016/j.clon.2019.10.010

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  7 in total

1.  Formulation of objective indices to quantify machine failure risk analysis for interruptions in radiotherapy.

Authors:  Daisuke Kawahara; Hisashi Nakano; Akito Saito; Yusuke Ochi; Yasushi Nagata
Journal:  J Appl Clin Med Phys       Date:  2020-12-16       Impact factor: 2.102

2.  Multivariate log file analysis for multi-leaf collimator failure prediction in radiotherapy delivery.

Authors:  Arkadiusz Mariusz Wojtasik; Matthew Bolt; Catharine H Clark; Andrew Nisbet; Tao Chen
Journal:  Phys Imaging Radiat Oncol       Date:  2020-08-10

3.  Treatment Interruptions During Stereotactic Body Radiotherapy for Prostate Cancer.

Authors:  Abigail N Pepin; Alan Zwart; Malika Danner; Marylin Ayoob; Thomas Yung; Brian T Collins; Deepak Kumar; Simeng Suy; Nima Aghdam; Sean P Collins
Journal:  Front Oncol       Date:  2022-01-19       Impact factor: 6.244

4.  Topic modeling of maintenance logs for linac failure modes and trends identification.

Authors:  Hongguang Yun; Marco Carlone; Zheng Liu
Journal:  J Appl Clin Med Phys       Date:  2021-11-29       Impact factor: 2.102

5.  Clinical Trials for Treatment and Prevention of HIV-Associated Malignancies in Sub-Saharan Africa: Building Capacity and Overcoming Barriers.

Authors:  Lilie L Lin; David S Lakomy; Elizabeth Y Chiao; Robert M Strother; Meg Wirth; Ethel Cesarman; Margaret Borok; Naftali Busakhala; Carla J Chibwesha; Lameck Chinula; Ntokozo Ndlovu; Jackson Orem; Warren Phipps; Vikash Sewram; Samantha L Vogt; Joseph A Sparano; Ronald T Mitsuyasu; Susan E Krown; Satish Gopal
Journal:  JCO Glob Oncol       Date:  2020-07

6.  Switching on prodrugs using radiotherapy.

Authors:  Jin Geng; Yichuan Zhang; Quan Gao; Kevin Neumann; Hua Dong; Hamish Porter; Mark Potter; Hua Ren; David Argyle; Mark Bradley
Journal:  Nat Chem       Date:  2021-06-10       Impact factor: 24.427

Review 7.  Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives.

Authors:  May Abdel-Wahab; Surbhi Grover; Eduardo Hernan Zubizarreta; Jose Alfredo Polo Rubio
Journal:  Brachytherapy       Date:  2020-09-11       Impact factor: 2.362

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.